TY - JOUR T1 - Carpe DM: The First Global Diabetes Targets JF - Global Health: Science and Practice JO - GLOB HEALTH SCI PRACT DO - 10.9745/GHSP-D-22-00403 VL - 11 IS - 2 SP - e2200403 AU - Jeremy I. Schwartz AU - Kaushik Ramaiya AU - Margo Warren AU - Prashant Yadav AU - Grace Castillo AU - Roshini George AU - Helen McGuire Y1 - 2023/04/28 UR - http://www.ghspjournal.org/content/11/2/e2200403.abstract N2 - Key MessagesDiabetes control is hampered by global inequities in care, which the new global diabetes targets aim to address.There are notable similarities and differences between the diabetes targets and the widely adopted HIV targets.These targets, combined with concrete operational plans, will help the global community focus efforts toward achieving global diabetes control.In May 2022, the 75th World Health Assembly adopted 5 groundbreaking global targets for diabetes mellitus (DM) for 2030.1 80% of people living with DM are diagnosed80% of those diagnosed achieve glycemic control80% of those diagnosed achieve blood pressure control60% of people with DM aged 40 years or older receive statins100% of people with type 1 DM have access to affordable insulin and blood glucose self-monitoring.The Global Diabetes Compact, which launched in 2021 on the centennial of insulin’s discovery, encompasses these targets. The Compact’s vision is to reduce the risk of diabetes and ensure everyone diagnosed with diabetes has access to equitable, comprehensive, affordable, and quality treatment and care.2The global prevalence of type 2 DM is expected to increase from 537 million in 2021 to 643 million in 2030 and to 783 million by 2045. The prevalence in sub-Saharan Africa will increase by 134% in that period, far more dramatically than in any other region.3 Vast global inequities shape access to quality DM prevention and care.4 Pharmaceutical access programs for DM medicines vary greatly in … ER -